{"disease":{"id":"prostate-cancer-recurrent","name":"prostate cancer recurrent"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT05384002","title":"An AI Platform Integrating Imaging Data and Models, Supporting Precision Care Through Prostate Cancer's Continuum","phase":"","overall_status":"COMPLETED","enrollment_count":14000,"lead_sponsor_name":"Fondazione del Piemonte per l'Oncologia","has_results":false},{"nct_id":"NCT03396874","title":"Gallium-68 PSMA-11 PET in Patients With Biochemical Recurrence","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":1435,"lead_sponsor_name":"University of Michigan","has_results":true},{"nct_id":"NCT01949337","title":"Enzalutamide With or Without Abiraterone and Prednisone in Treating Patients With Castration-Resistant Metastatic Prostate Cancer","phase":"PHASE3","overall_status":"UNKNOWN","enrollment_count":1311,"lead_sponsor_name":"Alliance for Clinical Trials in Oncology","has_results":true},{"nct_id":"NCT05352178","title":"Metastasis-directed Therapy for Oligorecurrent Prostate Cancer","phase":"PHASE3","overall_status":"RECRUITING","enrollment_count":873,"lead_sponsor_name":"Universitaire Ziekenhuizen KU Leuven","has_results":false},{"nct_id":"NCT07004582","title":"Lab Research Using Mini-tumors to Study Prostate Cancer Treatments","phase":"","overall_status":"NOT_YET_RECRUITING","enrollment_count":600,"lead_sponsor_name":"Maastricht Radiation Oncology","has_results":false},{"nct_id":"NCT06378866","title":"Stereotactic Body Radiation Therapy Plus Immediate or Delayed Androgen Receptor Pathway Inhibitor and Androgen Deprivation Therapy or Salvage Radiation Therapy for the Treatment of Prostate Cancer, DIVINE Trial","phase":"PHASE2","overall_status":"RECRUITING","enrollment_count":532,"lead_sponsor_name":"Mayo Clinic","has_results":false},{"nct_id":"NCT04787744","title":"Veterans Affairs Seamless Phase II/III Randomized Trial of STAndard Systemic theRapy With or Without PET-directed Local Therapy for Oligometastatic pRosTate Cancer","phase":"PHASE2, PHASE3","overall_status":"RECRUITING","enrollment_count":464,"lead_sponsor_name":"VA Office of Research and Development","has_results":false},{"nct_id":"NCT03507595","title":"Evaluation of the Metastasis and Recurrence of Prostate Cancer","phase":"","overall_status":"UNKNOWN","enrollment_count":400,"lead_sponsor_name":"Xinhua Hospital, Shanghai Jiao Tong University School of Medicine","has_results":false},{"nct_id":"NCT04026230","title":"Impact of Atorvastatin on Prostate Cancer Progression During ADT","phase":"PHASE3","overall_status":"UNKNOWN","enrollment_count":400,"lead_sponsor_name":"Tampere University Hospital","has_results":false},{"nct_id":"NCT05588128","title":"Prospective Monitoring of Subjects With Biochemically Recurrent Prostate Cancer Using 18FDCFPyL","phase":"","overall_status":"RECRUITING","enrollment_count":350,"lead_sponsor_name":"National Cancer Institute (NCI)","has_results":false},{"nct_id":"NCT04983628","title":"Molecular Profiling in Prostate Cancer","phase":"","overall_status":"UNKNOWN","enrollment_count":250,"lead_sponsor_name":"Hellenic Cooperative Oncology Group","has_results":false},{"nct_id":"NCT05045066","title":"Immunological Effects of Vitamin D Replacement Among Black/African American Prostate Cancer Patients","phase":"EARLY_PHASE1","overall_status":"RECRUITING","enrollment_count":220,"lead_sponsor_name":"Mayo Clinic","has_results":false},{"nct_id":"NCT06970847","title":"64Cu-SAR-bisPSMA Positron Emission Tomography: A Phase 3 Study of Participants With Biochemical Recurrence of Prostate Cancer","phase":"PHASE3","overall_status":"RECRUITING","enrollment_count":220,"lead_sponsor_name":"Clarity Pharmaceuticals Ltd","has_results":false},{"nct_id":"NCT03739684","title":"Study of 18F-DCFPyL PET/CT Imaging in Patients With Suspected Recurrence of Prostate Cancer","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":208,"lead_sponsor_name":"Progenics Pharmaceuticals, Inc.","has_results":true},{"nct_id":"NCT04102553","title":"F-18-PSMA-1007 Versus F-18-Fluorocholine PET in Patients With Biochemical Recurrence","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":200,"lead_sponsor_name":"ABX advanced biochemical compounds GmbH","has_results":false},{"nct_id":"NCT05022914","title":"PSMA Guided Approach for bIoCHEmical Relapse After Prostatectomy-PSICHE","phase":"","overall_status":"RECRUITING","enrollment_count":180,"lead_sponsor_name":"Azienda Ospedaliero-Universitaria Careggi","has_results":false},{"nct_id":"NCT05848011","title":"A Study of Lorigerlimab With Docetaxel or Docetaxel Alone in Participants With Metastatic Castration-Resistant Prostate Cancer","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":154,"lead_sponsor_name":"MacroGenics","has_results":false},{"nct_id":"NCT04324983","title":"Identification of Predictive Biomarkers","phase":"NA","overall_status":"COMPLETED","enrollment_count":150,"lead_sponsor_name":"Martini-Klinik am UKE GmbH","has_results":false},{"nct_id":"NCT04742361","title":"Efficacy of [18F]PSMA-1007 PET/CT in Patients With Biochemial Recurrent Prostate Cancer","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":136,"lead_sponsor_name":"ABX advanced biochemical compounds GmbH","has_results":false},{"nct_id":"NCT01802346","title":"Controlled Low Calorie Diet in Reducing Side Effects and Increasing Response to Chemotherapy in Patients With Breast or Prostate Cancer","phase":"NA","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":130,"lead_sponsor_name":"University of Southern California","has_results":false},{"nct_id":"NCT03443609","title":"Study of 68Ga-HBED-PSMA PET/CT and Conventional Imaging in Occult Biological Relapse Prostate Cancer","phase":"NA","overall_status":"COMPLETED","enrollment_count":130,"lead_sponsor_name":"Institut Cancerologie de l'Ouest","has_results":false},{"nct_id":"NCT03154190","title":"Health Care Coach Support in Reducing Acute Care Use and Cost in Patients With Cancer","phase":"NA","overall_status":"COMPLETED","enrollment_count":128,"lead_sponsor_name":"Stanford University","has_results":true},{"nct_id":"NCT04641078","title":"Stereotactic Body Radiotherapy With or Without Darolutamide for OligoRecurrent Prostate Cancer","phase":"PHASE2","overall_status":"UNKNOWN","enrollment_count":124,"lead_sponsor_name":"University Hospital, Ghent","has_results":false},{"nct_id":"NCT04891536","title":"Salvage Cryotherapy for Recurrent Prostate Cancer After Radiation Therapy","phase":"NA","overall_status":"RECRUITING","enrollment_count":100,"lead_sponsor_name":"Ignacio Puche Sanz","has_results":false},{"nct_id":"NCT04644822","title":"Safety and Efficacy of [18F]PSMA-1007 Injection in Suspected Persistent or Recurrent Prostate Cancer.","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":100,"lead_sponsor_name":"Centre for Probe Development and Commercialization","has_results":false},{"nct_id":"NCT01953640","title":"Gene Expression in Patients With Metastatic Prostate Cancer Receiving CYP-17 Inhibition Therapy","phase":"","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":92,"lead_sponsor_name":"Mayo Clinic","has_results":false},{"nct_id":"NCT02012296","title":"Enzalutamide and Mifepristone in Treating Patients With Metastatic Hormone Resistant Prostate Cancer","phase":"PHASE1, PHASE2","overall_status":"COMPLETED","enrollment_count":88,"lead_sponsor_name":"University of Chicago","has_results":true},{"nct_id":"NCT03350529","title":"MRI Guided Transurethral HIFU for Various Prostate Diseases","phase":"NA","overall_status":"COMPLETED","enrollment_count":87,"lead_sponsor_name":"Turku University Hospital","has_results":false},{"nct_id":"NCT04545957","title":"Jump: MR Simulation For Radiation Therapy Master Protocol","phase":"NA","overall_status":"RECRUITING","enrollment_count":86,"lead_sponsor_name":"Brigham and Women's Hospital","has_results":false},{"nct_id":"NCT07410494","title":"Biomarker-Guided Allogeneic Single-Target or Dual-Target CAR-NK Cell Therapy for Advanced Solid Tumors","phase":"PHASE1, PHASE2","overall_status":"RECRUITING","enrollment_count":85,"lead_sponsor_name":"Essen Biotech","has_results":false},{"nct_id":"NCT01519414","title":"Tivantinib in Treating Patients With Metastatic Prostate Cancer","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":78,"lead_sponsor_name":"National Cancer Institute (NCI)","has_results":true},{"nct_id":"NCT05036226","title":"COAST Therapy in Advanced Solid Tumors and Prostate Cancer","phase":"PHASE1, PHASE2","overall_status":"RECRUITING","enrollment_count":76,"lead_sponsor_name":"Medical University of South Carolina","has_results":false},{"nct_id":"NCT04541225","title":"Study of NUV-422 in Adults With Recurrent or Refractory High-grade Gliomas and Solid Tumors","phase":"PHASE1","overall_status":"TERMINATED","enrollment_count":74,"lead_sponsor_name":"Nuvation Bio Inc.","has_results":false},{"nct_id":"NCT02499835","title":"Vaccine Therapy and Pembrolizumab in Treating Patients With Hormone-Resistant, Metastatic Prostate Cancer","phase":"PHASE1, PHASE2","overall_status":"COMPLETED","enrollment_count":66,"lead_sponsor_name":"University of Wisconsin, Madison","has_results":true},{"nct_id":"NCT06096870","title":"Enzalutamide and PDS01ADC in PET Positive Recurrent Prostate Cancer (pprPC) Without Testosterone Lowering Therapy","phase":"PHASE2","overall_status":"RECRUITING","enrollment_count":65,"lead_sponsor_name":"National Cancer Institute (NCI)","has_results":false},{"nct_id":"NCT03122743","title":"Collection of Serum Samples in Studying Emotional Stress in Patients With Prostate Cancer","phase":"","overall_status":"COMPLETED","enrollment_count":61,"lead_sponsor_name":"Wake Forest University Health Sciences","has_results":false},{"nct_id":"NCT06957691","title":"Proof-of-Concept Trial to Assess the Efficacy and Safety of Fezolinetant in Improving Vasomotor Symptoms in Men With Prostate Cancer Undergoing Androgen Deprivation Therapy","phase":"PHASE2","overall_status":"RECRUITING","enrollment_count":60,"lead_sponsor_name":"Shehzad Basaria, M.D.","has_results":false},{"nct_id":"NCT02312557","title":"Pembrolizumab in Treating Patients With Metastatic Castration Resistant Prostate Cancer Previously Treated With Enzalutamide","phase":"PHASE2","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":58,"lead_sponsor_name":"OHSU Knight Cancer Institute","has_results":true},{"nct_id":"NCT01807065","title":"Sipuleucel-T With or Without Radiation Therapy in Treating Patients With Hormone-Resistant Metastatic Prostate Cancer","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":51,"lead_sponsor_name":"City of Hope Medical Center","has_results":true},{"nct_id":"NCT04686188","title":"Exploring the Mechanisms and Dynamics of Clonal Evolution Leading to Recurrence in Prostate Cancer","phase":"","overall_status":"UNKNOWN","enrollment_count":50,"lead_sponsor_name":"Institute of Cancer Research, United Kingdom","has_results":false},{"nct_id":"NCT03602079","title":"Study of A166 in Patients With Relapsed/Refractory Cancers Expressing HER2 Antigen or Having Amplified HER2 Gene","phase":"PHASE1, PHASE2","overall_status":"COMPLETED","enrollment_count":49,"lead_sponsor_name":"Klus Pharma Inc.","has_results":false},{"nct_id":"NCT01240629","title":"Doxorubicin-GnRH Agonist Conjugate AEZS-108 in Treating Patients With Metastatic Hormone-Resistant Prostate Cancer","phase":"PHASE1, PHASE2","overall_status":"COMPLETED","enrollment_count":43,"lead_sponsor_name":"University of Southern California","has_results":false},{"nct_id":"NCT01655836","title":"High-Dose Rate Brachytherapy and Stereotactic Body Radiation Therapy in Treating Patients With Prostate Cancer","phase":"PHASE1","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":42,"lead_sponsor_name":"Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University","has_results":false},{"nct_id":"NCT04550494","title":"Measuring the Effects of Talazoparib in Patients With Advanced Cancer and DNA Repair Variations","phase":"PHASE2","overall_status":"RECRUITING","enrollment_count":36,"lead_sponsor_name":"National Cancer Institute (NCI)","has_results":false},{"nct_id":"NCT04134130","title":"The Role of Follicle Stimulating Hormone in Advanced Prostate Cancer","phase":"NA","overall_status":"COMPLETED","enrollment_count":33,"lead_sponsor_name":"Lund University","has_results":false},{"nct_id":"NCT02601014","title":"Biomarker-Driven Therapy With Nivolumab and Ipilimumab in Treating Patients With Metastatic Hormone-Resistant Prostate Cancer Expressing AR-V7","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":32,"lead_sponsor_name":"Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins","has_results":true},{"nct_id":"NCT03389451","title":"68Ga PSMA PET for Patients With Biochemical Recurrence of Prostate Cancer","phase":"PHASE2, PHASE3","overall_status":"COMPLETED","enrollment_count":30,"lead_sponsor_name":"Michael Graham PhD, MD","has_results":true},{"nct_id":"NCT01093183","title":"Lenalidomide and Cyclophosphamide in Treating Patients With Previously Treated Hormone-Refractory Prostate Cancer","phase":"PHASE1, PHASE2","overall_status":"TERMINATED","enrollment_count":25,"lead_sponsor_name":"University of Nebraska","has_results":true},{"nct_id":"NCT04428203","title":"Epidiolex (CBD) in Patients With Biochemically Recurrent Prostate Cancer","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":21,"lead_sponsor_name":"Zin W Myint","has_results":true},{"nct_id":"NCT06508567","title":"Salvage MR-guided High-Dose-Rate Brachytherapy for Prostate Bed Recurrence After Radiotherapy in the PSMA PET Scan Era","phase":"NA","overall_status":"RECRUITING","enrollment_count":20,"lead_sponsor_name":"University Health Network, Toronto","has_results":false}],"total":50},"guidelines":[],"source":"Drug Landscape verified database"}